{
    "xml": "<topic id=\"PHP97401\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/elleste-solo-mx\" basename=\"elleste-solo-mx\" title=\"Elleste Solo MX\">\n<title>Elleste Solo<tm tmtype=\"reg\"/> MX</title>\n<topic id=\"PHP97435\" outputclass=\"indicationsAndDose\" rev=\"1.11\" parent=\"/clinical-medicinal-product-information/elleste-solo-mx\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Menopausal symptoms</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By transdermal application</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply 1&#8239;patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12&#8211;14 days of each cycle in women with a uterus, initiate therapy with <i>MX 40</i>, subsequently adjust according to response.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Osteoporosis prophylaxis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By transdermal application</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply 1&#8239;patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12&#8211;14 days of each cycle in women with a uterus, initiate therapy with <i>MX 80</i>, subsequently adjust according to response.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP97514\" outputclass=\"patientAndCarerAdvice\" rev=\"1.9\" parent=\"/clinical-medicinal-product-information/elleste-solo-mx\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patients should be advised on the application of Elleste Solo<tm tmtype=\"reg\"/> MX patches.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP97401",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/elleste-solo-mx",
    "basename": "elleste-solo-mx",
    "title": "Elleste Solo MX",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Menopausal symptoms",
                        "html": "Menopausal symptoms"
                    }
                ],
                "specificity": {
                    "routes": [
                        "transdermal application"
                    ],
                    "textContent": "By transdermal application",
                    "html": "By transdermal application"
                },
                "adult": [
                    {
                        "textContent": "Apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12&#8211;14 days of each cycle in women with a uterus, initiate therapy with MX 40, subsequently adjust according to response.",
                        "html": "<p>Apply 1&#8239;patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12&#8211;14 days of each cycle in women with a uterus, initiate therapy with <i>MX 40</i>, subsequently adjust according to response.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Osteoporosis prophylaxis",
                        "html": "Osteoporosis prophylaxis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "transdermal application"
                    ],
                    "textContent": "By transdermal application",
                    "html": "By transdermal application"
                },
                "adult": [
                    {
                        "textContent": "Apply 1 patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12&#8211;14 days of each cycle in women with a uterus, initiate therapy with MX 80, subsequently adjust according to response.",
                        "html": "<p>Apply 1&#8239;patch twice weekly continuously, started within 5 days of onset of menstruation (or at any time if cycles have ceased or are infrequent), to be used with cyclical progestogen for 12&#8211;14 days of each cycle in women with a uterus, initiate therapy with <i>MX 80</i>, subsequently adjust according to response.</p>"
                    }
                ]
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients should be advised on the application of Elleste Solo MX patches.",
                "html": "<p>Patients should be advised on the application of Elleste Solo<tm tmtype=\"reg\"/> MX patches.</p>"
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}